SCHEMBL18474181

SCHEMBL18474181

N/N=C/c1c(F)cccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
PBRM1 Q86U86 2/20 0.54
HTT P42858 2/20 0.53
LMNA P02545 1/20 0.53
ALDH1A1 P00352 4/20 0.51
GAA P10253 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
RECQL P46063 1/20 0.48
SLC22A1 O15245 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31470846 1.00 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19TDP1PBRM1
SCHEMBL29217466 0.84 POLB (0.50) CYP1A2CYP2C9CYP2C19TDP1PBRM1
SCHEMBL11887770 0.84 SLC22A1 (0.57) CYP1A2TDP1HTTLMNAALDH1A1
SCHEMBL10613416 0.84 SLC22A1 (0.57) CYP1A2TDP1HTTLMNAALDH1A1
SCHEMBL5302952 0.82 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19TDP1PBRM1
SCHEMBL29385007 0.82 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19TDP1PBRM1
SCHEMBL2164318 0.82 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19TDP1PBRM1
SCHEMBL2164321 0.82 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19TDP1PBRM1
SCHEMBL20502710 0.77 PBRM1 (0.55) CYP1A2CYP2C9CYP2C19TDP1PBRM1
SCHEMBL22538769 0.77 HTT (0.59) CYP1A2CYP2C9CYP2C19TDP1PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017021216-A1 METHOD OF TREATING CANCER WITH A COMBINATION OF BENZYLIDENEGUANIDINE DERIVATIVES AND CHEMOTHERAPEUTIC AGENT. INFLECTIS BIOSCIENCE (FR) 2017-02-09 WO disclosed